AUTHOR=Jeziorska Maria , Atkinson Andrew , Kass-Iliyya Lewis , Javed Saad , Kobylecki Christopher , Gosal David , Marshall Andrew , Silverdale Monty , Malik Rayaz A. 

TITLE=Increased Intraepidermal Nerve Fiber Degeneration and Impaired Regeneration Relate to Symptoms and Deficits in Parkinson's Disease

JOURNAL=Frontiers in Neurology

VOLUME=10

YEAR=2019

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.00111

DOI=10.3389/fneur.2019.00111

ISSN=1664-2295

ABSTRACT=<p><bold>Background:</bold> Previous studies have shown cutaneous small fiber pathology in patients with Parkinson's disease (PD). These studies have focused on nerve degeneration, but recent reports suggest that nerve regeneration may also be important in PD pathology.</p><p><bold>Objective:</bold> To establish the extent of intraepidermal nerve fiber (IENF) degeneration and regeneration and its relationship to clinical and neurological deficits in Parkinson's disease (PD).</p><p><bold>Methods:</bold> Twenty-three PD patients and 10 age-matched controls underwent skin biopsy and assessment of somatic and autonomic symptoms and deficits. We have assessed Intraepidermal Nerve Fiber Density (IENFD) using standard PGP9.5 staining and GAP-43 to assess Mean Axonal Length (MAL) and Intraepidermal Total Nerve Fiber Length (IETNFL).</p><p><bold>Results:</bold> IENFD (<italic>p</italic> &lt; 0.0001), MAL (<italic>p</italic> &lt; 0.0001), IETNFL/Area (<italic>p</italic> = 0.009), and IETNFL/Length (<italic>p</italic> = 0.04) were significantly reduced in patients with PD compared to controls. IENFD correlated significantly with disease duration (<italic>p</italic> = 0.03), cumulative levodopa dose (<italic>p</italic> = 0.02), Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III) (<italic>p</italic> = 0.01), Schwab and England Activities of Daily Living (ADL) (<italic>p</italic> = 0.03), NSP (<italic>p</italic> = 0.03), and 30:15 ratio (<italic>p</italic> = 0.03). IETNFL/Area correlated with the Autonomic Scale for Outcomes in Parkinson's Disease (SCOPA-AUT) (<italic>p</italic> = 0.03) and Diabetic Neuropathy Symptom score (DNS) (<italic>p</italic> = 0.04) and IETNFL/Length correlated with DNS (<italic>p</italic> = 0.03). MAL correlated with SCOPA-AUT (<italic>p</italic> = 0.01), DNS (<italic>p</italic> = 0.02), and DB-HRV (<italic>p</italic> = 0.02).</p><p><bold>Conclusion:</bold> Increased IENF degeneration and impaired regeneration correlates with somatic and autonomic symptoms and deficits in patients with PD.</p>